JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

A4487 WR 1065

Summary: P53/p21waf-1/MDM2 activator

≥26.7 mg/mL
A8218 Lapatinib
7 Citation

Target: ErbB

Summary: EGFR/HER2 inhibitor,potent,selective and reversible

≥29.05 mg/mL
A8210 GDC-0941
20 Citation

Target: PI3K

Summary: PI3K inhibitor,potent and selective

≥25.7 mg/mL
A5059 Edaravone

Summary: A radical scavenger and antioxidant
A5760 KRN 633

Summary: VEGFR inhibitor,ATP-competitive

insoluble in EtOH; insoluble in H2O; ≥13.75 mg/mL
A8335 Palbociclib (PD0332991) Isethionate
1 Citation

Target: Cyclin-Dependent Kinases

Summary: CDK4/6 inhibitor,highly selective

≥28.7 mg/mL
A8437 Gemcitabine
11 Citation

Summary: inhibitor of DNA synthesis

≥11.75 mg/mL
A8600 Tankyrase Inhibitors (TNKS) 22

Summary: Tankyrase inhibitor
B2184 GDC-0980 (RG7422)

Summary: Class I PI3K inhibitor for PI3Kα/β/δ/γ

≥21.35 mg/mL
B1621 TAK-733

Target: MEK

Summary: MEK allosteric site inhibitor

≥25.2 mg/mL